What is the price target for Southwest Airlines according to TD Cowen?
TD Cowen has a price target of $66 for Southwest Airlines, implying a 30% upside.
Finance / Stocks
Recent analyst updates suggest a positive outlook for Southwest Airlines and Palantir Technologies, driven by strengthening passenger demand and strategic positioning in the AI sector, respectively.
TD Cowen's bullish stance on Southwest Airlines is driven by increasing seat demand against disciplined supply in 2026. Analyst Tom Fitzgerald anticipates Southwest management will raise forward earnings guidance. The analyst's updated earnings estimate is approximately 20% above consensus for 2026 and 30% above consensus for 2027.
UBS's upgrade of Palantir reflects the stock’s valuation after a 35% decline from its peak. The firm forecasts 70% revenue growth in 2026 and stable margins in the mid-50% range. The increasing support for its commercial business and potential additional defense contracts could strengthen its leadership in military AI.
TD Cowen has a price target of $66 for Southwest Airlines, implying a 30% upside.
UBS upgraded Palantir due to its position at the nexus of AI and data, expecting strong revenue growth and stable margins.
Do you think these analyst predictions will hold true? Share your thoughts in the comments below!
Share this article with others who need to stay ahead of this trend!
This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.
All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.
This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.
Always do your own research (DYOR) before making any decisions based on the information presented.